Adagrasib, Cetuximab May Benefit KRASG12c Colorectal Cancer Patients miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
The Goldman Sachs Group lowered shares of Jacobio Pharmaceuticals Group (OTCMKTS:JBPHF – Free Report) from a buy rating to a neutral rating in a research note published on Wednesday morning, FlyOnTheWall reports. Jacobio Pharmaceuticals Group Price Performance Shares of OTCMKTS:JBPHF opened at $0.48 on Wednesday. Jacobio Pharmaceuticals Group has a 1 year low of $0.60 […]
Chinese PE fund manager CICC Capital secures $649m second close of biomedicine fund Premium
CICC Capital, the private equity (PE) fund management platform of Hong Kong-listed investment bank CICC, has reached the second closing of its biomedicine fund at over 4.2 billion yuan ($648.7 million), said the firm in a WeChat post on Monday.
Continue reading this story with a subscription to DealStreetAsia.
Contact us for corporate subscriptions at subs@dealstreetasia.com.
Sign up for our newsletter - The Daily Brief Opt out of receiving The Daily Brief in your inbox everyday
REGISTER stories left placeholder You have one free story left this month.
Qiming, Hillhouse-backed biotech firm Jacobio raises $174m in HK IPO
Laboratory equipment. Photo: Pixabay Premium
Jacobio Pharmaceuticals Group, a Chinese clinical-stage pharmaceutical firm focusing on oncology therapies, has raised about HK$1.35 billion ($174.1 million) in an initial public offering (IPO) on the main board of the Stock Exchange of Hong Kong on Monday.
Continue reading this story with a subscription to DealStreetAsia.
Contact us for corporate subscriptions at subs@dealstreetasia.com.
Sign up for our newsletter - The Daily Brief Opt out of receiving The Daily Brief in your inbox everyday
REGISTER stories left placeholder You have one free story left this month.